OpGen Webinar – A corporate and business update from the front lines of the fight against AMR

OpGen Webinar – A corporate and business update from the front lines of the fight against AMR

OpGen — 5 videos in collection

More on this equity

This interactive webinar with OpGen’s CEO Oliver Schacht, CFO Tim Dec and COO Johannes Bacher highlights recent progress in the fight against Antimicrobial Resistance. The presentation includes updates on R&D progress, FDA and NMPA regulatory reviews and pending approvals, upcoming clinical trials, and business development and partnering opportunities. The speakers also comment on key corporate development topics around the shareholder support required to authorise new shares for future strategic development and financing.


You may also be interested in these:

Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.